In new publication, 96% of clinicians state that treatment plans informed using the MolecuLight procedure led to improved wound healing

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the publication of an independent consensus study of 32 leading wound care clinicians in Diagnostics.

Published results provides guidelines to standardize use of fluorescence imaging among wound care providers to enhance the quality of patient care

(Please see full press release)